Angiotensin-converting enzyme 2 (ACE2) is upregulated in the lung tissue and serum of COVID-19 ARDS and unrelated ARDS, whereas a loss of type 2 alveolar epithelial (AT2) cells is selectively observed in COVID-19 ARDS. The gene discussed is ACE2; the disease is acute respiratory distress syndrome.